Canara HSBC Life IPO GMP

Facebook
Reddit
Telegram
WhatsApp

Check out Canara HSBC Life IPO GMP IPO Grey Market Premium, IPO Details, IPO Date, Review, Price, Allotment Details, Company Financial Report, IPO Valuation, IPO Registrar Details, Company Details and IPO Lead Managers to Sauda rates as of today. Canara HSBC Life IPO GMP is started now. Stay tuned for the latest IPO GMP numbers of Canara HSBC Life IPO.

Canara HSBC Life IPO, a joint venture between Canara Bank and HSBC Insurance (Asia Pacific), is poised for its public debut with an IPO scheduled to open on October 10, 2025, and close on October 14, 2025, with anchor bids called on October 9, 2025. The company has set a price band of ₹100 to ₹106 per share, targeting a valuation of approximately ₹10,000 crore at the upper end. This offering is structured as a 100% Offer-for-Sale (OFS) of up to 23.75 crore equity shares, implying that the company itself will not raise fresh capital; instead, existing shareholders (Canara Bank, HSBC Insurance, and Punjab National Bank) will divest part of their stakes. Retail investors must apply for a minimum of 140 shares, amounting to roughly ₹14,840 at the upper band. The IPO allocation is apportioned with 50% reserved for Qualified Institutional Buyers (QIBs), 35% for retail investors, and 15% for Non-Institutional Investors (NIIs). A strong portion of interest has already come from anchor investors: the company raised about ₹750 crore via anchor allocations, with mutual funds and institutional players heavily participating. Market watchers are closely monitoring IPO GMP, which in early grey-market quotes shows a premium, signalling positive investor sentiment and expectations of a strong listing performance. Considering the brand strength, bancassurance reach, and backing by major financial institutions, the Canara HSBC Life IPO is expected to be a high-profile offering in the insurance space.

Canara HSBC Life IPO Details

IPO Open Date
October 10, 2025
IPO Close Date
October 14, 2025
Face Value
₹10 Per Equity Share
IPO Price Band
₹100 to ₹106 Per Share
Issue Size
Approx ₹2,517.50 Crores
Fresh Issue
Offer for Sale
Approx 23,75,00,000 Equity Shares
Lot Size
140 Shares
IPO Listing
BSE & NSE
Retail Quota
Not more than 35%
QIB Quota
Not more than 50%
NII Quota
Not more than 15%

Canara HSBC Life IPO Market Lot

Application
Lot Size
Shares
Amount
Retail Minimum
1
140
₹14,840
Retail Maximum
13
1820
₹1,92,920
S-HNI Minimum
14
1960
₹2,07,760
B-HNI Minimum
67
9380
₹9,94,280

Canara HSBC Life IPO Dates

IPO Open Date
October 10, 2025
IPO Close Date
October 14, 2025
Basis of Allotment
October 15, 2025
Refunds
October 16, 2025
Credit to Demat Account
October 16, 2025
IPO Listing Date
October 17, 2025

Promoters of Canara HSBC Life IPO

The promoters of the company are Canara Bank and HSBC Insurance (Asia-Pacific) Holdings Limited.

About Canara HSBC Life IPO

Canara HSBC Life IPO, a strategic joint venture between Canara Bank (51%), HSBC Insurance (Asia Pacific) (26%), and Punjab National Bank (23%), is preparing for one of the most anticipated IPOs in the insurance sector. The public offering is scheduled from October 10 to October 14, 2025, with anchor investor bids opening a day before, on October 9, 2025. The price band for the issue is ₹100 to ₹106 per share, which would place the valuation of the company at close to ₹10,000 crore at the upper end. Importantly, this IPO is a complete Offer-for-Sale (OFS) transaction, with no fresh capital infusion—existing shareholders will sell their equity holdings to investors. The OFS is sized at 23.75 crore equity shares, including 13.77 crore shares from Canara Bank, 4.75 lakh shares from HSBC, and 9.50 crore shares from PNB. The allocation of shares is divided as 50% to Qualified Institutional Buyers (QIBs), 35% to retail investors, and 15% to Non-Institutional Investors (NIIs). Retail participants must apply in multiples of 140 shares, making the minimum investment roughly ₹14,840 at the top price band. The company has already secured strong anchor support, raising around ₹750 crore through anchor allocations, with funds such as ICICI Prudential MF, HDFC MF, and others being significant participants. Investors are watching IPO GMP closely; early indications show positive premium in the grey market, suggesting healthy expectations for listing gains. Canara HSBC distributes its life insurance portfolio largely through bancassurance, leveraging the branch networks of Canara Bank and PNB, supplemented by digital and agency channels. Post IPO, the company plans to expand distribution, launch newer life and health insurance products, and deepen its penetration in under-served markets. The listing is expected to follow allotment and share credit procedures, positioning the IPO as a marquee offering in India’s insurance and capital markets.

Canara HSBC Life IPO Company Financial Report

Amount ₹ in Crores.

Period Ended
Revenue
Expense
Profit After Tax
Assets
2023
₹261.59
₹161.77
₹91.19
₹30,548.89
2024
₹240.88
₹117.00
₹113.32
₹37,815.80
2025
₹234.01
₹105.87
₹116.98
₹41,852.09
Canara HSBC Life IPO Valuation
KPI Values
ROE: -%
ROCE: -%
EBITDA Margin: -%
PAT Margin: -%
Debt to equity ratio:
Earning Per Share (EPS): ₹1.23 (Basic)
Price/Earning P/E Ratio: N/A
Return on Net Worth (RoNW): 7.97%
Net Asset Value (NAV): ₹15.97
IPO Lead Managers
  • SBI Capital Markets Ltd.
  • BNP Paribas
  • HSBC Securities & Capital Markets (India) Pvt.Ltd.
  • JM Financial Ltd.
  • Motilal Oswal Investment Advisors Ltd.
Objects of the Issue
Registrar Contact Details

Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: einward.ris@kfintech.com
Website: https://ipostatus.kfintech.com/

Company Contact Details

Canara HSBC Life Insurance Co.Ltd.
8 th Floor, Unit No. 808- 814,
Ambadeep Building, Kasturba Gandhi Marg,
Connaught Place, Central Delhi
Delhi, New Delhi, 110001
Phone: +91 01244506761
Email: investor@canarahsbclife.in
Website: http://www.canarahsbclife.com/

Leave a Reply

Your email address will not be published. Required fields are marked *

Picture of Team IPO Researcher

Team IPO Researcher

An IPO market specialist with extensive knowledge of stock markets, research, and equity strategies. He brings sharp insights into upcoming IPOs, investor participation, grey market premium (GMP) movements, and post-listing trends, delivering in-depth reviews, recommendations, and technical evaluations.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.